The Morrison Government will contribute an additional $50 million to the COVAX Advance Market Commitment (COVAX AMC) to ensure more people in our region and across the world have access to safe and effective COVID-19 vaccines.
This additional contribution will help COVAX deliver on its objective of vaccinating 30% of populations of AMC countries, from an original goal to reach 20% of their populations.
Australia has now committed a total of $130 million to COVAX AMC.
Australia’s support for COVAX complements our $623 million Regional Vaccine Access and Health Security Initiative – which is assisting our Pacific and Southeast Asian neighbours to access and administer safe and effective COVID-19 vaccines.
This includes $100 million for our Quad partnership with Japan, the US and India to deliver a billion doses to Southeast Asia by the end of 2022.
Our neighbours in the Pacific and Southeast Asia have now received more than 13 million doses from COVAX, with more deliveries planned.
These vaccines are being prioritised for high-risk individuals, health workers, frontline personnel and vulnerable groups.
Australia’s contribution will assist the COVAX AMC to deliver more than 1.8 billion doses worldwide, reaching at least 114 million people in Southeast Asia and the Pacific.
Skip to content